Literature DB >> 32201031

Clarifying the direction of impact of negative symptoms and neurocognition on prospective work functioning in psychosis: A 20-year longitudinal study.

Lauren Luther1, Jennifer H Suor2, Cherise Rosen3, Thomas H Jobe4, Robert N Faull5, Martin Harrow6.   

Abstract

Both neurocognition and negative symptoms have demonstrated strong links to functional outcomes, such as work functioning, among those with severe mental illness (SMI). Prior models have suggested that reduced neurocognition 1) precedes or predicts greater negative symptoms and 2) indirectly influences functional outcomes via its impact on negative symptoms. The current study sought to also test a divergent model: whether greater negative symptoms predict reduced neurocognition and indirectly influence work functioning through their impact on neurocognition. Both models were tested using cross-sectional and prospective data spanning 20-years in a sample of 277 people with a SMI with psychotic features. Results showed that both models were supported in cross-sectional analyses. However, in prospective models predicting work functioning, only the models examining the indirect influence of negative symptoms on work functioning (7.5 to up to 20-years later) through neurocognition demonstrated significant mediation (i.e., a significant indirect effect); further, higher negative symptoms significantly predicted lower prospective neurocognition, while lower neurocognition did not significantly predict greater prospective negative symptoms. Although cross-sectional data were consistent with prior models, our prospective models offered greater support for a putative causal pathway running from negative symptoms to neurocognition-rather than the reverse-to work functioning. Findings have implications for mechanisms contributing to longitudinal work functioning and suggest that targeting negative symptoms prior to neurocognition could be more beneficial for long-term work outcomes.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Negative symptoms; Neurocognition; Psychosis; Severe mental illness; Vocational rehabilitation; Work

Mesh:

Year:  2020        PMID: 32201031     DOI: 10.1016/j.schres.2020.03.012

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  8 in total

1.  Cognitive, community functioning and clinical correlates of the Clinical Assessment Interview for Negative Symptoms (CAINS) in psychotic disorders.

Authors:  Manuel J Cuesta; Ana M Sánchez-Torres; Ruth Lorente-Omeñaca; Lucía Moreno-Izco; Victor Peralta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-09-07       Impact factor: 5.270

2.  Identifying subgroups based on self-assessment of ability in patients with schizophrenia and its relationship with vocational outcomes.

Authors:  Hiroki Okada
Journal:  Hong Kong J Occup Ther       Date:  2022-02-17       Impact factor: 1.476

3.  A word is worth a thousand pictures: A 20-year comparative analysis of aberrant abstraction in schizophrenia, affective psychosis, and non-psychotic depression.

Authors:  Cherise Rosen; Martin Harrow; Liping Tong; Thomas H Jobe; Helen Harrow
Journal:  Schizophr Res       Date:  2021-09-22       Impact factor: 4.939

4.  Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia.

Authors:  Michael Davidson; Jay Saoud; Corinne Staner; Nadine Noel; Sandra Werner; Elisabeth Luthringer; David Walling; Mark Weiser; Philip D Harvey; Gregory P Strauss; Remy Luthringer
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 7.348

5.  Neurocognition and Social Cognition Predicting 1-Year Outcomes in First-Episode Psychosis.

Authors:  Maija Lindgren; Minna Holm; Tuula Kieseppä; Jaana Suvisaari
Journal:  Front Psychiatry       Date:  2020-12-04       Impact factor: 4.157

6.  Association of Negative Symptoms of Schizophrenia Assessed by the BNSS and SNS Scales With Neuropsychological Performance: A Gender Effect.

Authors:  Paweł Wójciak; Klaudia Domowicz; Marta Zabłocka; Michał Michalak; Janusz K Rybakowski
Journal:  Front Psychiatry       Date:  2021-12-24       Impact factor: 4.157

7.  'An experience of meaning': A 20-year prospective analysis of delusional realities in schizophrenia and affective psychoses.

Authors:  Cherise Rosen; Martin Harrow; Clara Humpston; Liping Tong; Thomas H Jobe; Helen Harrow
Journal:  Front Psychiatry       Date:  2022-08-04       Impact factor: 5.435

8.  The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study.

Authors:  Elmars Rancans; Zsófia Borbála Dombi; Péter Mátrai; Ágota Barabássy; Barbara Sebe; Iveta Skrivele; György Németh
Journal:  Int Clin Psychopharmacol       Date:  2021-05-01       Impact factor: 2.023

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.